JNP3, a new compound, suppresses PMA-induced tumor cell invasion via NF-κB down regulation in MCF-7 breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 421, Issue 2, 2012, Pages 190-196

  Yu, Hai Yang ^a   Kim, Kyoung Sook ^a   Moon, Hyung In ^a   Kim, Kyung Mi ^a   Lee, Young Choon ^a   Lee, Jai Heon ^a  

^a Dong A University   (South Korea)

Author keywords

Invasion; JNP3; MCF 7 cells; MMP 9; NF B

Indexed keywords

CHINESE DRUG; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JNP 3; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INVASION; CELL INVASION; CELL MIGRATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; PHOSPHORYLATION; TETRADECANOYLPHORBOL ACETATE; TRITERPENES;

EID: 84860473633     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.03.133     Document Type: Article

References (20)

1. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 2006, 25:9-34.
2. Sternlicht M.D., Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 2001, 17:463-516.
3. Yan C., Boyd D.D. Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. 2007, 211:19-26.
4. Westermarck J., Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999, 13:781-792.
5. Stamenkovic I. Extracellular matrix remodeling: the role of matrix metalloproteinases. J. Path. 2003, 200:448-464.
6. H.J. Cho, J.H. Kang, J.Y. Kwak, et al. Ascofuranone suppresses PMA-mediated matrix metalloproteinase-9 gene activation through the Ras/Raf/MEK/ERK-andAP-1dependent mechanisms, Carcinogenesis 28 (2007) 1104-1110.
7. Hong S., Park K.K., Magae J., et al. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through theERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion ofrenal carcinoma cells. J. Biol. Chem. 2005, 280:25202-25209.
8. Lin C.W., Hou W.C., Shen S.C., et al. Quercetin inhibition of tumor invasion via suppressing PKCδ/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008, 29:1807-1815.
9. Kim K.S., Yao L., Lee Y.C., et al. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK1/2 signaling pathway in MCF-7 human breast cancer cells. Immunopharm. Immunol. 2010, 32:600-606.
10. Yao L., Kim K.S., Kang N.Y., et al. Inhibitory effect of a traditional Chinese formulation, Hyul-Tong-Ryung, on PMA-inducedMMP-9 expression in MCF-7 human breast carcinoma cells. J. Trad. Med. 2009, 26:25-34.
11. Hayes P.Y., Chow S., Somerville M.J., et al. Daphnane- and tigliane-type diterpenoid esters and orthoesters from Pimelea elongate. J. Nat. Prod. 2010, 73(11):1907-1913.
12. Chung T.W., Moon S.K., Chang Y.C., et al. Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism. FASEB J. 2004, 18:1670-1681.
13. Lee S.O., Jeong Y.J., Kim M., et al. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-κB-dependent MMP-9 expression. Biochem. Biophys. Res. Commun. 2008, 366:1019-1024.
14. Huang Q., Shen H.M., Ong C.N. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-κB. Biochem. Pharmacol. 2004, 68:361-371.
15. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 2000, 18:621-663.
16. Shin M., Yan C., Boyd D. An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNA-binding and PMA-inducible 92-kDa type IV collagenase expression. Biochim. Biophys. Acta 2002, 1589:311-316.
17. S.S. Lakka, S.L. Jasti, A.P. Kyritsis, et al. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades, Clin. Exp. Metastasis18 (2000) 245-252.
18. Taguchi A., Blood D.C., del Toro G., et al. Blockade of RAGE-amphoter in signalling suppresses tumour growth and metastases. Nature 2000, 405:354-360.
19. Hidalgo M., Eckhardt S.G. Development of matrix metalloproteinase inhibitors in cancer therapy. J. Natl. Cancer Inst. 2001, 93:178-193.
20. Vihinen P., Ala-aho R., Kahari V.M. Matrix metalloproteinases as therapeutic targets in cancer. Curr. Cancer Drug Targets 2005, 5:203-220.